Firings at Federal Health Agencies Decimate Offices That Release Public Records

Tags: FOIA, public health transparency, Robert F. Kennedy Jr., CDC, FDA, NIH, government accountability, health policy, public records access

Mass Layoffs Undermine Transparency Efforts

Public access to vital federal health records is facing a major setback following the firing of key Freedom of Information Act (FOIA) staff across the Department of Health and Human Services (HHS). Transparency advocates and health experts warn that these layoffs will drastically slow the release of records documenting outbreaks, safety violations, and product failures at medical facilities and manufacturers.

The cuts, initiated by HHS Secretary Robert F. Kennedy Jr., affected FOIA offices within major health agencies, including the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH). According to six current and former agency staffers, the eliminated roles were crucial for managing the complex requests that keep government health agencies accountable.

A Blow to Public Oversight

FOIA is a cornerstone of government transparency, granting the public access to internal agency documents. These records have long been used to uncover corruption, policy failures, and public health threats. At HHS, FOIA requests frequently retrieve documents related to foodborne outbreaks, inspections of pharmaceutical and medical manufacturing facilities, and vaccine safety data.

Critics say the mass firings contradict Kennedy’s pledge of “radical transparency.” Peter Lurie, president of the Center for Science in the Public Interest, called the move “antithetical” to that promise and warned it would harm public health oversight. “You need FOIA to take the lid off,” he said, referring to the importance of exposing hidden dangers within federal operations.

Official Response and Criticism

In response to inquiries, HHS said the restructuring aims to make the department more efficient by consolidating previously siloed FOIA offices. “The work will continue,” said spokesperson Vianca Rodriguez Feliciano in a statement. However, many transparency advocates remain unconvinced.

Gunita Singh, a staff attorney for the Reporters Committee for Freedom of the Press, said the firings are likely to worsen an already backlogged system. “What we need is the opposite of what’s happening now: hiring more staff,” she said.

During the COVID-19 pandemic, FOIA requests exposed internal FDA documents that contradicted public endorsements of certain drugs, such as hydroxychloroquine. Without such tools, Singh warned, vital health information could remain hidden from the public.

Broader Implications for Health and Safety

The implications stretch far beyond journalism. Researchers, attorneys, advocacy groups, and public watchdogs depend on FOIA to study clinical trials, investigate adverse drug reactions, and monitor safety standards. The loss of experienced staff could render these efforts ineffective.

Michael Morisy, CEO of the nonprofit MuckRock, said that sacking FOIA staff strips agencies of institutional knowledge critical for processing complex requests. “We are sacking the entire staff and all of that knowledge,” he said. “And I just don’t see how these things continue to function.”

With tens of thousands of FOIA requests flowing into HHS agencies annually, including more than 15,000 last fiscal year alone, the system’s collapse would have serious consequences. From food safety to vaccine monitoring, Americans would know less about their government’s health operations — and be less able to hold those in power accountable.

As concerns mount, transparency advocates urge a reversal of course, emphasizing that true transparency can’t exist without the infrastructure to support it.